Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
JCO Oncology Practice
|
June 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis
Garth W Strohbehn, Molly C Tokaz, Daniel Sanghoon Shin, et al.
JAMA Internal Medicine
|
May 7, 2019
Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer
Reith R Sarkar, J Kellog Parsons, Alex K Bryant, et al.
Cancer Medicine
|
June 20, 2024
Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advances
Alex K Bryant, Rafael Zamora-Resendiz, Xin Dai, et al.
Cancer Medicine
|
November 7, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System
Sean R Miller, Matthew Schipper, Lars G Fritsche, et al.
The Lancet. Oncology
|
May 31, 2024
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system
Alex K Bryant, Jacqueline R Lewy, R Daniel Bressler, et al.
American Journal of Clinical Oncology
|
March 10, 2022
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer
Alex K Bryant, Huiying Yin, Matthew J Schipper, et al.
The Lancet. Oncology
|
November 17, 2024
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study
Sean Miller, Ralph Jiang, Matthew Schipper, et al.
JAMA Network Open
|
March 20, 2024
Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes
Rana R McKay, Tyler J Nelson, Meghana S Pagadala, et al.
Cancer
|
June 10, 2024
Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancer
Donna M Edwards, Mina Pirzadeh, Tony Van, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 16, 2025
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer
Sean R Miller, Dana H Chung, Rachel T Gonzalez, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
JCO Oncology Practice
|
June 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis
Garth W Strohbehn, Molly C Tokaz, Daniel Sanghoon Shin, et al.
JAMA Internal Medicine
|
May 7, 2019
Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer
Reith R Sarkar, J Kellog Parsons, Alex K Bryant, et al.
Cancer Medicine
|
June 20, 2024
Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advances
Alex K Bryant, Rafael Zamora-Resendiz, Xin Dai, et al.
Cancer Medicine
|
November 7, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System
Sean R Miller, Matthew Schipper, Lars G Fritsche, et al.
The Lancet. Oncology
|
May 31, 2024
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system
Alex K Bryant, Jacqueline R Lewy, R Daniel Bressler, et al.
American Journal of Clinical Oncology
|
March 10, 2022
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer
Alex K Bryant, Huiying Yin, Matthew J Schipper, et al.
The Lancet. Oncology
|
November 17, 2024
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study
Sean Miller, Ralph Jiang, Matthew Schipper, et al.
JAMA Network Open
|
March 20, 2024
Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes
Rana R McKay, Tyler J Nelson, Meghana S Pagadala, et al.
Cancer
|
June 10, 2024
Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancer
Donna M Edwards, Mina Pirzadeh, Tony Van, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 16, 2025
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer
Sean R Miller, Dana H Chung, Rachel T Gonzalez, et al.
Page
of 8